Search Results 311-320 of 17044 for pharmacogenetics

  1. Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques - Mayo Clinic

    The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta ...

  2. Video Center - Center for Individualized Medicine - Mayo Clinic Research

    ... pharmacogenetic drug interactions and drug metabolism. At that time, pharmacogenomics was not a word in my vocabulary, but it was on the horizon. As a ...

  3. Longitudinal Characterization and Genetic Analysis of Pediatric-Onset Morphea - Mayo Clinic

    About this study. The purpose of this project is to determine the genetic causes of disease and establish accurate clinical indicators and biomarkers of ...

  4. Prognostic Risk Evaluation for Hypereosinophilic Syndrome (HES) and Idiopathic Hypereosinophilia (IHE) and the Role of Next-generation Sequencing - Mayo Clinic

    About this study. The purpose of this study is to: To identify predictors of inferior overall survival in HES/IHE patients including molecular parameters ...

  5. A Study to Evaluate Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease - Mayo Clinic

    The purpose of this study is to investigate how abrupt loss of ovarian hormones following bilateral oophorectomy affects overall aging, physical performance, ...

  6. A Study of the Genetic Links of Type 2 Diabetes in Latino Families - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Radhika Dhamija, M.B.B.S. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Radhika Dhamija, M.B.B.S., is a neurologist and geneticist specializing in rare and undiagnosed diseases.

  8. Monoclonal gammopathy of undetermined significance (MGUS) - Doctors and departments - Mayo Clinic

    A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.

  9. Cancer Clinical Trials - Medical Professionals

    The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

  10. Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation - Mayo Clinic

    About this study. The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney ...